Top 10 Articles 2012 & 2011

Top articles 2012

1 = Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.
Waters, PJ; McKeon, A; Leite, MI; et al.
NEUROLOGY  Volume: 78   Issue: 9   Pages: 665-671   Published: FEB 2012
Times Cited: 70 (from Web of Science Core Collection)

2 = Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.
Silberstein, SD; Holland, S; Freitag, F; et al.
NEUROLOGY  Volume: 78   Issue: 17   Pages: 1337-1345   Published: APR 2012 Times Cited: 66 (from Web of Science Core Collection)

3 = Total daily physical activity and the risk of AD and cognitive decline in older adults. Buchman, AS; Boyle, PA; Yu, L; et al.
NEUROLOGY  Volume: 78   Issue: 17   Pages: 1323-1329   Published: APR 2012 Times Cited: 56 (from Web of Science Core Collection)

4 = Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures.
Krauss, GL; Serratosa, JM; Villanueva, V; et al.
NEUROLOGY  Volume: 78   Issue: 18   Pages: 1408-1415   Published: MAY 2012
Times Cited: 56 (from Web of Science Core Collection)  

5 v Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial.
Coles, AJ; Fox, E; Vladic, A; et al.
NEUROLOGY  Volume: 78   Issue: 14   Pages: 1069-1078   Published: APR 2012 Times Cited: 54 (from Web of Science Core Collection) 

6 v Patterns of treatment response in newly diagnosed epilepsy.
Brodie, MJ; Barry, SJE; Bamagous, GA; et al.
NEUROLOGY  Volume: 78   Issue: 20   Pages: 1548-1554   Published: MAY 2012
Times Cited: 53 (from Web of Science Core Collection)

7 v Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial
Coelho, T; Maia, LF; da Silva, AM; et al.
NEUROLOGY  Volume: 79   Issue: 8   Pages: 785-792   Published: AUG 2012 Full Text
Times Cited: 51 (from Web of Science Core Collection)

8 v A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.
Richard, IH; McDermott, MP; Kurlan, R; et al.
NEUROLOGY  Volume: 78   Issue: 16   Pages: 1229-1236   Published: APR 2012
Times Cited: 50 (from Web of Science Core Collection)  

Top articles 2011

1 = Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria Polman, CH.; Reingold, SC; Banwell, B; et al.
ANNALS OF NEUROLOGY Volume: 69 Issue: 2 Pages: 292-302 Published: FEB 2011
Times Cited: 685 (from Web of Science) A comment to this top article can be found here.

2 = Responsive cortical stimulation for the treatment of medically intractable partial epilepsy
Morrell, MJ; RNS Syst Epilepsy Study Grp
NEUROLOGY Volume: 77 Issue: 13 Pages: 1295-1304 Published: SEP 2011
Times Cited: 111 (from Web of Science)

3 = Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS
Zivadinov, R; Marr, K; Cutter, G; et al.
NEUROLOGY Volume: 77 Issue: 2 Pages: 138-144 Published: JUL 2011
Times Cited: 92 (from Web of Science)

4 = Sun exposure and vitamin D are independent risk factors for CNS demyelination Lucas, RM; Ponsonby, A-L; Dear, K; et al.
NEUROLOGY Volume: 76 Issue: 6 Pages: 540-548 Published: FEB 8 2011
Times Cited: 85 (from Web of Science)

5 = Guidelines in practice: treatment of painful diabetic neuropathy Bril,
V.; England, J.; Franklin, G. M.; et al.
NEUROLOGY Volume: 76 Issue: 20 Pages: 1758-1765 Published: MAY 2011
Times Cited: 77 (from Web of Science)

5 ˄ Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
O’Connor, PW; Goodman, A; Kappos, L; et al.
NEUROLOGY Volume: 76 Issue: 22 Pages: 1858-1865 Published: MAY 2011
Times Cited: 77 (from Web of Science)

6 ˄ Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline.
Debette, S; Seshadri, S; Beiser, A; et al.
NEUROLOGY Volume: 77 Issue: 5 Pages: 461-468 Published: AUG 2011
Times Cited: 70 (from Web of Science Core Collection)

7 ˄ Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy
French, JA.; Abou-Khalil, BW; Leroy, RF; et al. RESTORE 1 Study 301 Investigators NEUROLOGY Volume: 76 Issue: 18 Pages: 1555-1563 Published: MAY 2011
Times Cited: 69 (from Web of Science)

7 ˄ Default mode network connectivity in stable vs progressive mild cognitive impairment
Petrella, JR; Sheldon, FC; Prince, SE; et al.
NEUROLOGY.; Volume 76 Issue:6: Pages: 511-7. FEB 8 2011
Times Cited: 69 (from Web of Science)

8 v Screening for tumours in paraneoplastic syndromes: report of an EFNS task force Titulaer, MJ; Soffietti, R; Dalmau, J; et al.
EUROPEAN JOURNAL OF NEUROLOGY Volume: 18 Issue: 1 Pages: 19-E3 Published: JAN 2011
Times Cited: 68 (from Web of Science) A comment to this top article can be found here.

9 ˄ Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
Li, J; Wang, YJ; Zhang, M; et al. Chongqing Ageing Study Grp
NEUROLOGY Volume: 76 Issue: 17 Pages: 1485-1491 Published: APR 2011
Times Cited: 60 (from Web of Science)

9 ˄ Use of iboprofen and risk of Parkison disease
Gao, X; Chen, H; Schwarzschild, MA; et al.
NEUROLOGY Volume: 76 Issue: 10 Pages: 863-869 Published: MAR 2011
Times Cited: 60 (from Web of Science)

10 ˄ Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study.
Koivunen, J; Scheinin, N; Virta, JR; et al.
NEUROLOGY Volume: 76 Issue: 12 Pages: 1085-1090 Published: MAR 2011
Times Cited: 58 (from Web of Science Core Collection)

10 = Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Cortese, I.; Chaudhry, V.; So, Y. T.; et al.
NEUROLOGY Volume: 76 Issue: 3 Pages: 294-300 Published: JAN 18 2011
Times Cited: 58 (from Web of Science Core Collection)

Share this...

Facebook

Twitter

Linkedin